News

One of those is Boston-based Syntis Bio, which is working on a daily pill that mimics the effects of gastric bypass—no actual surgery required. Today, the company announced early data from animals and ...
The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...
Danish pharmaceutical company Novo Nordisk — best known for its blockbuster weight-loss drugs Ozempic and Wegovy — has signed ...
CERN’s LHCb experiment confirms CP violation in baryons, marking a milestone in particle physics; Japan unveils the world’s ...